Inventor · disambiguated record
Hongkui Zeng
Also filed as: ZENG HONGKUI
6 granted patents·22 pending applications·44 citations·filing 2003–2024
82Inventor score
Top patents by PatentIndex Score
28 records- 0191US7786139B2PDE10 inhibitors and related compositions and methodsOMEROS CORP·Filed 2008·Granted Aug 31, 2010·16 cites·13 claims
- 0289US8278327B2PDE10 inhibitors and related compositions and methodsBERGMANN JOHN E·Filed 2010·Granted Oct 2, 2012·14 cites·16 claims
- 0379US8999654B2Method of identifying a compound for the treatment or prevention of obesityGAITANARIS GEORGE A·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 0478US9119822B2Use of PDE7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2013·Granted Sep 1, 2015·3 cites·37 claims
- 0577US10292374B2G protein coupled receptor 85 and SREB3 knockout mice and uses thereofOMEROS CORP·Filed 2016·Granted May 21, 2019·1 cites·4 claims
- 0676US8637528B2Use of PDE7 inhibitors for the treatment of movement disordersBERGMANN JOHN E·Filed 2009·Granted Jan 28, 2014·3 cites·52 claims
- 0769US2025236886A1Artificial expression constructs for selectively modulating gene expression in excitatory cortical neuronsALLEN INST·Filed 2024·Application pending·0 cites
- 0861US2009178153A1G protein coupled receptors and uses thereofOMEROS CORP·Filed 2008·Application pending·0 cites
- 0959US2008260643A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2008·Application pending·0 cites
- 1055US2016219845A1G protein coupled receptors and uses thereofOMEROS CORP·Filed 2015·Application pending·0 cites
- 1155US2025163458A1Artificial expression constructs for modulating gene expression in dopaminergic neuronsALLEN INST·Filed 2023·Application pending·0 cites
- 1255US2019183824A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2018·Application pending·0 cites
- 1354US2008260744A1G protein coupled receptors and uses thereofOMEROS CORP·Filed 2007·Application pending·0 cites
- 1453US2025235550A1Artificial expression constructs for modulating gene expression in the cerebellum and a secondary cell typeALLEN INST·Filed 2022·Application pending·0 cites
- 1553US2013247233A1G protein coupled receptors and uses thereofGAITANARIS GEORGE A·Filed 2013·Application pending·0 cites
- 1651US2016282365A1G protein coupled receptors and uses thereofOMEROS CORP·Filed 2016·Application pending·0 cites
- 1751US2024254514A1Artificial expression constructs for modulating gene expression in neurons within the thalamusALLEN INST·Filed 2022·Application pending·0 cites
- 1850US2006134109A1G protein coupled receptors and uses thereofNURA INC·Filed 2003·Application pending·0 cites
- 1950US2021395780A1Artificial expression constructs for selectively modulating gene expression in excitatory cortical neuronsALLEN INST·Filed 2019·Application pending·0 cites
- 2050US2011185439A1G protein coupled receptors and uses thereofOMEROS CORP·Filed 2010·Application pending·0 cites
- 2149US2024018543A1Artificial expression constructs for modulating gene expression in chandelier cellsALLEN INST·Filed 2021·Application pending·0 cites
- 2248US2023302158A1Artificial expression constructs for modulating gene expression in striatal neuronsALLEN INST·Filed 2021·Application pending·0 cites
- 2348US2011091388A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2010·Application pending·0 cites
- 2447US2023212608A1Artificial expression constructs for selectively modulating gene expression in inhibitory neocortical neuronsALLEN INST·Filed 2021·Application pending·0 cites
- 2546US2016015715A1Use of pde7 inhibitors for the treatment of movement disordersOMEROS CORP·Filed 2015·Application pending·0 cites
- 2646US2023117172A1Artificial expression constructs for selectively modulating gene expression in non-neuronal brain cellsALLEN INST·Filed 2021·Application pending·0 cites
- 2743US2022249703A1Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populationsALLEN INST·Filed 2020·Application pending·0 cites
- 2842US2023159952A1Artificial expression constructs for selectively modulating gene expression in neocortical layer 5 glutamatergic neuronsALLEN INST·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →